Human papillomavirus (HPV) has long been recognized as the causative agent of cervical
cancer. High-risk HPV types 16 and 18 alone are responsible for over 70% of all cases of …

Human papillomavirus (HPV) has been associated with several human cancers, including
cervical cancer, vulvar cancer, vaginal and anal cancer, and a subset of head and neck …

In 2014 and 2021, two nucleic-acid vaccine candidates named MAV E2 and VGX-3100
completed phase III clinical trials in Mexico and US, respectively, for patients with human …

Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …

It is now well established that most cervical cancers are causally associated with HPV
infection. This realization has led to efforts to control HPV-associated malignancy through …

Human papillomavirus (HPV), the most common sexually transmitted virus, and its
associated diseases continue to cause significant morbidity and mortality in over 600 million …

Human papillomavirus (HPV), particularly type 16, has been associated with more than 99%
of cervical cancers. There are two HPV oncogenic proteins, E6 and E7, which play a major …

High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and
oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by …

A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …

Human papillomavirus (HPV) infection is responsible for all cervical cancer cases, other
anogenital cancers, and head and neck tumors. The epidemiological relevance of HPV …